Table: Sapporo Clinical Lab -2022/23 parent results

Sapporo Clinical Laboratory

12/05/2023 07:30

May 12 (Reuters)- 
          Sapporo Clinical Laboratory Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           17.61           17.74          16.91         8.26    
               (-0.7 pct)      (+8.3 pct)     (-4.0 pct)    (-5.9 pct) 
  Operating      705 mln           1.46                                
               (-51.8 pct)     (+33.1 pct)                             
  Recurring      895 mln           1.57         522 mln      224 mln   
               (-42.9 pct)     (+33.9 pct)    (-41.6 pct)  (-42.3 pct) 
  Net            471 mln           1.02         355 mln      151 mln   
               (-53.9 pct)     (+29.5 pct)    (-24.7 pct)  (-22.7 pct) 
  EPS          141.47 yen      300.67 yen     106.71 yen    45.30 yen  
  Ann Div       23.00 yen       23.00 yen      23.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       23.00 yen       23.00 yen      23.00 yen               
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T